|
BIVM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
5.204000E-04 |
| Normal-vs-Stage3 |
1.984440E-03 |
| Normal-vs-Stage4 |
1.613550E-02 |
| Stage1-vs-Stage2 |
3.820400E-01 |
| Stage1-vs-Stage3 |
2.528200E-01 |
| Stage1-vs-Stage4 |
4.063200E-01 |
| Stage2-vs-Stage3 |
2.103600E-01 |
| Stage2-vs-Stage4 |
2.976800E-01 |
| Stage3-vs-Stage4 |
9.678600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.52879997550315E-09 |
| Normal-vs-Asian |
1.472230E-01 |
| Caucasian-vs-AfricanAmerican |
3.433600E-01 |
| Caucasian-vs-Asian |
2.639800E-01 |
| AfricanAmerican-vs-Asian |
2.494600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.11459996787744E-09 |
| Male-vs-Female |
9.703000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.60789999887379E-08 |
| Normal-vs-Extreme_Weight |
1.64401825486493E-12 |
| Normal-vs-Obese |
4.6917025819937E-11 |
| Normal-vs-Extreme_Obese |
1.781680E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.683000E-01 |
| Normal_Weight-vs-Obese |
6.224200E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.337200E-01 |
| Extreme_Weight-vs-Obese |
3.145400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.054200E-01 |
| Obese-vs-Extreme_Obese |
8.314800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.777400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.002400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.873900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.141000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.628000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.517900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.129780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.658600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.6149999999836E-06 |
| Normal-VS-KIRP CIMP |
8.758800E-01 |
| Normal-VS-Unclassified PRCC |
4.29369999999096E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.02970004639747E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.34240000004837E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
4.480600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.298500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.754000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.50989999994733E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23949994712547E-09 |
| Normal-vs-N1 |
1.977830E-03 |
| Normal-vs-N2 |
3.942000E-01 |
| N0-vs-N1 |
5.318000E-01 |
| N0-vs-N2 |
2.017700E-02 |
| N1-vs-N2 |
2.318500E-03 |
|
|
